Provided by Tiger Fintech (Singapore) Pte. Ltd.

Takeda Pharmaceutical Co Ltd

14.90
+0.03000.20%
Post-market: 14.900.00000.00%16:41 EDT
Volume:1.37M
Turnover:20.52M
Market Cap:45.58B
PE:36.00
High:15.02
Open:15.00
Low:14.88
Close:14.87
Loading ...

Neurocrine Amends Agreement With Takeda for Major Depressive Disorder Treatment

Dow Jones
·
28 Jan

Neurocrine announces amendment to collaboration with Takeda

TIPRANKS
·
28 Jan

Keros to Receive $200 Million From Takeda In Connection to Elritercept License Deal

MT Newswires Live
·
21 Jan

Takeda Recognized as a Top Employer in Canada for Third Consecutive Year

CNW Group
·
21 Jan

Keros Therapeutics Announces Effectiveness of Global License Agreement with Takeda to Advance Elritercept

GlobeNewswire
·
21 Jan

Takeda Canada Says Health Canada Granted Market Authorization for Fruzaqla

MT Newswires Live
·
21 Jan

Takeda's FRUZAQLA™ (fruquintinib) Receives Health Canada Market Authorization for Metastatic Colorectal Cancer (mCRC)

CNW Group
·
20 Jan

ADMA Stock Catapults 275.7% in a Year: How Should You Play the Stock?

Zacks
·
11 Jan

Verizon Frontline showcases advanced communications solutions at EDGE25

GlobeNewswire
·
02 Jan

Sector Update: Health Care Stocks Mixed Pre-Bell Friday

MT Newswires Live
·
27 Dec 2024

Takeda's HYQVIA Approved in Japan To Treat Immunodeficiency

Benzinga
·
27 Dec 2024

Takeda announces Japan MHLW approval for new Hyqvia use

TIPRANKS
·
27 Dec 2024

Takeda Pharmaceutical's Hyqvia Approved in Japan for Patients With Immune Disorders

MT Newswires Live
·
27 Dec 2024

TD Cowen Reaffirms Their Buy Rating on Takeda Pharmaceutical Company (TAK)

TIPRANKS
·
21 Dec 2024

Takeda Sponsors MILESTONE Canada Advanced Inflammatory Bowel Disease (IBD) Fellowship Initiative

CNW Group
·
19 Dec 2024

Takeda Announces Subsidiary Liquidation and Merger Completion

TipRanks
·
19 Dec 2024